Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Swiss Re AG (SREN.SW)
Zurich, CH
Swiss Re AG, along with its affiliated entities, operates internationally as a prominent provider of diverse risk management solutions. Its offerings extend to wholesale reinsurance, direct insurance products, various forms of insurance-based risk transfer, and associated services. The company's extensive operations are primarily channeled through three key business divisions: Property & Casualty Reinsurance, Life & Health Reinsurance, and Corporate Solutions. Specifically, the Property & Casualty Reinsurance unit undertakes the underwriting of a comprehensive array of risks. This includes property-related coverages like general property, credit and surety, engineering, aviation, marine, agriculture, retakaful, and facultative solutions. It also encompasses casualty reinsurance for areas such as general liability, motor vehicle, workers' compensation, personal accident, management and professional liability, and cyber threats, alongside facultative options. The Life & Health Reinsurance segment specializes in underwriting solutions for both life and health insurance portfolios. The Corporate Solutions division provides tailored risk transfer products, ranging from standardized covers and multi-line programs to highly customized insurance solutions for businesses. Its extensive client base spans various sectors, including stock and mutual insurance carriers, government and public bodies, medium to large enterprises, and private individuals. Established in 1863, the company maintains its headquarters in Zurich, Switzerland.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -2.30% | -2.18% | -9.51% | -6.26% | -20.13% | -6.84% | -18.32% | +34.72% | +39.11% | +40.66% | +222.73% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 1 | +1 |
| Buy | 0 | 0 |
| Hold | 10 | 0 |
| Sell | 2 | 0 |
| Strong Sell | 4 | 0 |
-
Revenue growth Insurance - Reinsurance: +19.7%+7.4% Q4'25: -2.9% (vs Q4'23)
-
EPS growth Insurance - Reinsurance: +47.7%+54.3% ★ Q4'25: +27.1% (vs Q4'23)
-
FCF margin FCF growth · Insurance - Reinsurance: +7.0%+7.9% Q4'25: +6.3% (vs Q4'23)
-
EBIT margin Insurance - Reinsurance: +13.4%+13.7% ★ Q4'25: +12.5% (vs Q4'23)
-
ROIC Insurance - Reinsurance: +4.0%+17.3% ★ Q4'25: +30.4% (vs Q4'23)
-
Share dilution Insurance - Reinsurance: +0.2%+1.2% Q4'25: -2.2% (vs Q4'23)
-
Debt / EBITDA Net debt/EBITDA · Insurance - Reinsurance: 0.00×1.31× Q4'25: 0.72× (vs Q4'23)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2011 actual |
Dec 2012 actual |
Dec 2013 actual |
Dec 2014 actual |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 10 Rev. Ana. 12 EPS Ana. |
Dec 2027 9 Rev. Ana. 12 EPS Ana. |
Dec 2028 8 Rev. Ana. 13 EPS Ana. |
Dec 2029 7 Rev. Ana. 11 EPS Ana. |
Dec 2030 7 Rev. Ana. 5 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
27.80B
est: 28.60B (-2.8%)
|
33.52B
est: 33.72B (-0.6%)
|
36.55B
est: 38.07B (-4.0%)
|
37.27B
est: 37.98B (-1.9%)
|
35.66B
est: 30.26B (+17.9%)
|
43.75B
est: 32.89B (+33.0%)
|
42.39B
est: 33.93B (+24.9%)
|
36.88B
est: 33.68B (+9.5%)
|
49.16B
est: 36.05B (+36.4%)
|
43.78B
est: 36.09B (+21.3%)
|
45.94B
est: 38.82B (+18.3%)
|
46.04B
est: 41.63B (+10.6%)
|
43.64B
est: 57.17B (-23.7%)
|
46.76B
est: 45.07B (+3.7%)
|
50.22B
est: 43.57B (+15.3%)
|
42.65B
41.27B – 44.29B
-2.1% YoY
|
43.46B
41.77B – 46.20B
+1.9% YoY
|
44.63B
43.03B – 46.89B
+2.7% YoY
|
46.43B
44.77B – 48.79B
+4.0% YoY
|
48.05B
46.34B – 50.49B
+3.5% YoY
|
| EBITDA |
6.84B
est: 4.30B (+59.0%)
|
10.15B
est: 6.24B (+62.6%)
|
5.99B
est: 10.20B (-41.3%)
|
5.41B
est: 5.60B (-3.5%)
|
6.55B
est: 4.26B (+53.8%)
|
5.62B
est: 6.03B (-6.8%)
|
1.63B
est: 4.39B (-62.8%)
|
1.44B
est: 788.32M (+82.2%)
|
2.04B
est: 44.11M (+4,515.6%)
|
115.00M
est: 1.51B (-92.4%)
|
3.07B
est: 1.52B (+102.3%)
|
1.65B
est: 1.56B (+5.6%)
|
4.26B
est: 4.90B (-13.0%)
|
4.27B
est: 3.92B (+8.8%)
|
6.87B
est: 3.73B (+84.2%)
|
3.65B
3.53B – 3.79B
-2.1% YoY
|
3.72B
3.58B – 3.96B
+1.9% YoY
|
3.82B
3.69B – 4.02B
+2.7% YoY
|
3.98B
3.83B – 4.18B
+4.0% YoY
|
4.12B
3.97B – 4.32B
+3.5% YoY
|
| EBIT |
3.73B
est: 4.19B (-11.1%)
|
6.26B
est: 4.68B (+33.7%)
|
5.59B
est: 7.48B (-25.4%)
|
4.95B
est: 6.03B (-17.9%)
|
5.95B
est: 4.25B (+40.0%)
|
4.98B
est: 6.48B (-23.2%)
|
1.09B
est: 4.51B (-75.8%)
|
1.11B
est: 943.38M (+17.1%)
|
1.50B
est: 1.48B (+1.6%)
|
-502.00M
est: 1.11B (-145.1%)
|
2.40B
est: 1.12B (+115.2%)
|
1.22B
est: 1.15B (+6.5%)
|
4.35B
est: 4.73B (-8.0%)
|
4.59B
est: 3.79B (+21.2%)
|
6.87B
est: 3.60B (+90.7%)
|
3.53B
3.41B – 3.66B
-2.1% YoY
|
3.59B
3.45B – 3.82B
+1.9% YoY
|
3.69B
3.56B – 3.88B
+2.7% YoY
|
3.84B
3.70B – 4.04B
+4.0% YoY
|
3.97B
3.83B – 4.18B
+3.5% YoY
|
| Net Income |
2.63B
est: 2.20B (+19.3%)
|
4.26B
est: 3.30B (+29.0%)
|
4.51B
est: 5.09B (-11.4%)
|
3.57B
est: 5.22B (-31.6%)
|
4.67B
est: 3.41B (+36.9%)
|
3.63B
est: 5.20B (-30.3%)
|
398.00M
est: 3.43B (-88.4%)
|
462.00M
est: 431.57M (+7.1%)
|
727.00M
est: 497.06M (+46.3%)
|
-878.00M
est: 825.55M (-206.4%)
|
1.44B
est: 827.03M (+73.8%)
|
472.00M
est: 1.76B (-73.2%)
|
3.11B
est: 3.95B (-21.3%)
|
3.24B
est: 3.13B (+3.6%)
|
4.97B
est: 4.98B (-0.4%)
|
4.76B
4.48B – 5.03B
-4.6% YoY
|
4.80B
4.22B – 5.38B
+0.9% YoY
|
4.35B
3.35B – 5.35B
-9.3% YoY
|
5.30B
5.06B – 5.65B
+21.9% YoY
|
5.66B
5.40B – 6.03B
+6.7% YoY
|
| SGA |
—
est: 3.75B (-100.0%)
|
—
est: 76.63M (-100.0%)
|
—
est: 3.54B (-100.0%)
|
—
est: 4.26B (-100.0%)
|
—
est: 1.47B (-100.0%)
|
—
est: 1.30B (-100.0%)
|
—
est: 4.83B (-100.0%)
|
—
est: 3.58B (-100.0%)
|
—
est: -1.11B (+100.0%)
|
—
est: 5.26B (-100.0%)
|
—
est: 5.27B (-100.0%)
|
—
est: 5.42B (-100.0%)
|
—
|
—
|
—
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
| EPS |
7.68
est: 5.76 (+33.3%)
|
11.85
est: 10.69 (+10.8%)
|
11.89
est: 12.31 (-3.4%)
|
9.39
est: 11.18 (-16.0%)
|
12.28
est: 12.53 (-2.0%)
|
9.82
est: 10.94 (-10.2%)
|
1.03
est: 0.50 (+107.7%)
|
1.51
est: 3.09 (-51.1%)
|
2.46
est: 4.17 (-41.1%)
|
-3.04
est: -2.58 (-17.9%)
|
4.97
est: 5.78 (-14.1%)
|
1.63
est: 1.47 (+10.5%)
|
10.53
est: 13.60 (-22.6%)
|
10.88
est: 10.37 (+4.9%)
|
16.63
est: 16.65 (-0.1%)
|
15.77
14.98 – 16.85
-5.3% YoY
|
15.94
14.12 – 17.99
+1.1% YoY
|
16.62
11.21 – 17.91
+4.3% YoY
|
17.75
16.93 – 18.92
+6.8% YoY
|
18.94
18.06 – 20.19
+6.7% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-12 | A | 4/5 | 5/5 | 5/5 | 5/5 | 3/5 | 3/5 | 2/5 |
| 2026-05-11 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 3/5 | 1/5 |
| 2026-05-08 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 3/5 | 1/5 |
| 2026-05-07 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 3/5 | 1/5 |
| 2026-05-06 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 2/5 | 3/5 | 1/5 |
| 2026-05-05 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 3/5 | 1/5 |
| 2026-05-04 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 3/5 | 1/5 |
| 2026-04-30 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 3/5 | 1/5 |
| 2026-04-29 | A | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 3/5 | 2/5 |
| 2026-04-28 | A | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 3/5 | 2/5 |
| 2026-04-27 | A | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 3/5 | 2/5 |
| 2026-04-24 | A | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 3/5 | 2/5 |
| 2026-04-23 | A | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 3/5 | 2/5 |
| 2026-04-22 | A | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 3/5 | 2/5 |
| 2026-04-21 | A | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 3/5 | 2/5 |
| 2026-04-20 | A | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 3/5 | 2/5 |
| 2026-04-17 | A | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 3/5 | 2/5 |
| 2026-04-16 | A | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 3/5 | 2/5 |
| 2026-04-15 | A | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 3/5 | 2/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Alexander Andreas Berger | Group Chief Executive Officer | 4M | male |
| Anders Malmstrom | Group Chief Financial Officer | — | — |
| Beat Strebel | Head of the Middle East & Africa business | — | male |
| Elena Logutenkova | Head of Media Relations & Corporate Reporting Group Communications | — | female |
| Hermann Geiger | Group Chief Legal Officer and Head of Legal & Compliance | — | male |
| Mark Senkevics | MD and Head of Property & Casualty Underwriting - Asia, Australia & New Zealand | — | male |
| Nicole Pieterse | Group Chief People Officer | — | female |
| Pravina Ladva | Group Chief Digital & Technology Officer | — | female |
| Thomas Bohun | Head of Investor Relations | — | male |
| Velina Peneva | Group Chief Investment Officer and Co-Head Client Solutions & Analytics of Swiss Re Asset Management | — | female |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for SREN.SW
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
